Could cause temporary or reversible harm; serious harm is unlikely.
Failed dissolution specifications.
| Brand name | DIVALPROEX SODIUM |
| Generic name | DIVALPROEX SODIUM |
| Active ingredient(s) | DIVALPROEX SODIUM |
| Distributed by / for | Amneal Pharmaceuticals, Bridgewater, NJ |
| NDC | 65162-755-10 |
| Full product label | Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10 |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC |
| Distribution | USA nationwide |
| Quantity | 4,309 bottles |
| Recall initiated | 2022-07-27 |
| Report date | 2022-08-31 |
| Recall completed | 2023-08-17 |
| Recall number | D-1362-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Brookhaven NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗